Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The questionnaire comprised five sections: MPU as measured by the Chinese version of the 10-Item Mobile Phone Problem Use Scale (CMPPUS-10); depressive symptoms according to the Depression Anxiety Stress Scale-21 Chinese Version (DASS-21); bodily pain according to the Brief Pain Inventory Short Form Chinese (BPISF-C); daytime sleepiness as measured using the Chinese version of the Epworth Sleepiness Scale (CESS) and socio-demographic questions.
|
31076240 |
2020 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Compared to those in the lowest tertile, subjects in the highest tertile of DASH score had lower means of GHQ-12 total score (mean difference - 4.6; P < 0.001), DASS-21 total score (mean difference - 9.1; P < 0.001), and DASS-21 depression, anxiety, and stress subscale scores (mean differences for depression, anxiety, and stress - 3.6, - 2.4, and - 3.2, respectively; all P < 0.001).
|
31020399 |
2020 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Childhood abuse was assessed with the Childhood Trauma Questionnaire at interview and current symptoms were assessed using the 21-item Depression Anxiety and Stress Scale (DASS-21).
|
30561144 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
BICAMS: Brief International Cognitive Assessment for Multiple Sclerosis BVMT-R: Brief Visuospatial Memory Test Revised CVLT: California Verbal Learning Test DASS: Depression Anxiety Stress Scale EDSS: Expanded Disability Status Scale MS: Multiple Sclerosis NNT: Numbers Needed to Treat PS: Propensity Score PSAI: Pythagorean Self-Awareness Intervention RR: Relapsing Remitting SDMT: Symbol Digits Modalities Test VAS-PF: Visual Analogue Scale Physical Fatigue.
|
30451648 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
The results obtained in this study, evaluated with the DASS-42 test, confirm that REAC-NPO and REAC-NPPO neuromodulation treatments can be useful tools for the clinical treatment of depression, anxiety, and stress, as already proven by previous results evaluated with different psychometric tests.
|
30858704 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Participants with brain tumour completed the Brief Test of Adult Cognition by Telephone, Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), ratings of physical symptoms, Depression Scale of the Depression Anxiety Stress Scales-21 (DASS-Depression), and Generalized Anxiety Disorder-7 (GAD-7) scale.
|
31313128 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Thus, the current study investigated rate of visual information processing in 67 young university students (<i>M</i> age = 19.64 years) and 33 educated healthy older adults (<i>M</i> age = 70.33 years), while accounting for depression, anxiety and stress symptoms using the DASS.
|
31156422 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Women admitted to an MBU completed the Edinburgh Postnatal Depression Scale (EPDS), Depression, Anxiety and Stress Scale (DASS-21), Karitane Parenting Confidence Scale (KPCS) and Maternal Postnatal Attachment Scale (MPAS) at admission, discharge and 3 months following discharge.
|
31675945 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Reliability and psychometric validity of Hindi version of Depression, Anxiety and Stress Scale-21 (DASS-21) for Hindi speaking Head Neck Cancer and Oral Potentially Malignant Disorders Patients.
|
31169235 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Demographic, behavioural and disease-related factors were also assessed and the Depression, Anxiety and Stress Scale (DASS 21) was used for psychological well-being.
|
31823657 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Psychological status was determined using the Depression Anxiety and Stress Scale (DASS-21).
|
31850355 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Depressivity was measured using the Depression, Anxiety and Stress Scale (DASS-21).
|
30936845 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Out of 118, 96 mothers consented to be screened and were asked to fill out the 21-item Depression Anxiety and Stress Scale-21 (DASS-21) questionnaire.
|
31327298 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Participants completed measures that assess healthcare microaggressions and daily discrimination as well as the Depression, Anxiety and Stress Scale (DASS-21).
|
30721264 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
<i>Methods:</i> Three hundred and fifty-five outpatients (mean age = 38.70, SD = 11.00, 244 males, range 18-71 years) undergoing Cognitive-Behavioral Therapy for alcohol dependence completed the Toronto Alexithymia Scale (TAS-20), Depression Anxiety Stress Scales (DASS-21), Obsessive Compulsive Drinking Scale (OCDS), and Alcohol Use Disorders Identification Test (AUDIT) prior to the first treatment session.
|
31429362 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The WHELM survey tool was developed within the Australian maternity context and includes a number of validated measures: The Copenhagen Burnout Inventory (CBI), Depression, Anxiety and Stress Scale (DASS-21), as well as items from the Royal College of Midwives (RCM) 'Why Midwives Leave' study (Ball et al., 2002).
|
31473405 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Psychiatric evaluation included structured psychiatric interviewing and assessment of symptoms of depression, anxiety and stress using Depression Anxiety Stress Scale (DASS 21).<b>Results<i>:</i></b> The prevalence of PNES with epilepsy was 4.97% and diagnosed after a mean interval of 7.12yrs from onset of the first attack.
|
31771384 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
We administered the South Oaks Gambling Inventory (SOGS, Lesieur and Blume in Am J Psychiatry 144(9):1184-1188, 1987), the 21-item Depression Anxiety Stress Scale (DASS-21, Lovibond and Lovibond in Manual for the depression anxiety stress scales.
|
30746606 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The change in DASS-21 subset (depression, anxiety, and stress) correlated with the change in total SGRQ score, at P < .001.
|
30594559 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
The measures included sociodemographic questions, internet and health-related variables, the Internet Addiction Test (IAT) and the Depression, Anxiety and Stress Scale (DASS-21).
|
31323534 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
One hundred and fifty-five non-clinical adults completed the Young Parenting Inventory (YPI) regarding both their mothers and fathers, Young's Schema Questionnaire (YSQ), the State/Trait Anger Scale (STAS) and the Depression Anxiety Stress Scale-21 (DASS-21).
|
31454593 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Participants were administered the South Oaks Gambling Screen (SOGS), the Consideration of Future Consequences scale (CFC-14), the Prospective and Retrospective Memory Questionnaire (PRMQ), as well as the Depression, Anxiety and Stress Scales-21 (DASS-21).
|
31112912 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Depression, Anxiety and Stress Scale-21 (DASS-21) were used to assess psychological problems among patients.
|
31533764 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The Depression Anxiety Stress Scale 21 (DASS-21) was used for psychometric evaluation.
|
31178457 |
2019 |
Mixed anxiety and depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The demographic variables, pain, patient global assessment, laboratory, clinical findings, diseases activity scores, Beck Depression Inventory (BDI) and Depression Anxiety and Stress Scale-short version (DASS-21) were collected.
|
31309294 |
2019 |